Geron (GERN) - P/S ratio

P/S ratio as of January 2025 (TTM): 60.7

According to Geron's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 6.12. At the end of 2024 the company had a P/S ratio of 93.4.

P/S ratio history for Geron from 2001 to 2024

PS ratio at the end of each year

Year	P/S ratio	Change
2024	93.4	-98.07%
2023	> 1000	212.34%
2022	> 1000	448.99%
2021	282	-85.55%
2020	> 1000	230.29%
2019	591	237.86%
2018	175	-35.03%
2017	269	403.4%
2016	53.5	153.02%
2015	21.1	-95.24%
2014	444	-8.08%
2013	483	612.18%
2012	67.8	-15.06%
2011	79.8	-55.29%
2010	179	-39.99%
2009	298	125.56%
2008	132	132.7%
2007	56.7	-69.97%
2006	189	-90.19%
2005	> 1000	343.97%
2004	434	4.85%
2003	413	427.29%
2002	78.4	33.28%
2001	58.8

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
Eterna Therapeutics ERNA	40.3	-33.63%	🇺🇸 USA
Gilead Sciences GILD	4.09	-93.25%	🇺🇸 USA
Bio-Techne TECH	10.7	-82.40%	🇺🇸 USA
Incyte INCY	3.47	-94.28%	🇺🇸 USA
CTI BioPharma CTIC	15.8	-73.93%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for Geron (GERN)

P/S ratio as of January 2025 (TTM): 60.7